Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs

Lungpacer Medical revealed promising data at the American Transplant Congress 2026 showing that their transvenous phrenic nerve stimulation method significantly boosts the availability of donor lungs that meet transplant criteria. This breakthrough could reduce lung collapse, offering a crucial lifeline for critically ill patients waiting for transplants. The implications of this innovation are huge, potentially transforming the landscape of lung transplantation and saving many lives by expanding the pool of viable donor organs.